|Articles|April 22, 2011

Study Says Wellmune WGP Effective Against Ragweed Allergies

Research on the beta glucan ingredient was presented at the Experimental Biology 2011 conference.

Wellmune WGP may be effective in reducing symptoms of ragweed allergy, according to new research presented by Biothera (Eagan, MN) at the recent Experimental Biology 2011 conference.

Allergies to ragweed pollen affect an estimated 36 million Americans, according to Biothera, and the symptoms aren’t friendly: nasal congestion, sneezing, difficulty in breathing, and itchy eyes.

In a placebo-controlled, double blinded study, 48 healthy subjects were assigned to 250 mg of Wellmune WGP or placebo daily for four weeks. Subjects were located in an area of southeast Ohio where ragweed pollen counts are deemed high.

After four weeks of supplementation, researchers concluded that Wellmune WGP was associated with statistically significant reductions in symptoms and severity of general ragweed allergy and nasal- and eye-specific allergy symptoms.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.